News
NOVO NORDISK: INVESTIGATIONAL CAGRISEMA 2.4MG/2.4MG SHOWED 25% AVERAGE WEIGHT LOSS IN WOMEN IN REDEFINE 1 POST HOC ANALYSIS
Oct 20, 2026 · ThinkSabio Blog
NOVO NORDISK: INVESTIGATIONAL CAGRISEMA 2.4MG/2.4MG SHOWED 25% AVERAGE WEIGHT LOSS IN WOMEN IN REDEFINE 1 POST HOC ANALYSIS
20-OCT-2026 08:29 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
